Richard William Scalzo Dyne Therapeutics, Inc. (DYN) insider trading activity

Richard William Scalzo is SVP, Head of Finance & Admin. of Dyne Therapeutics, Inc.. Currently has a direct ownership of 122,330 shares of DYN, which is worth approximately $999,436. The most recent transaction as insider was on Jan 03, 2024, when has been sold 13,000 shares (Common Stock) at a price of $1.03 per share, resulting in proceeds of $13,390. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 122K

3.74% 3M change

2.55% 12M change

Total Value Held $999,436

Richard William Scalzo Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 03 2024	BUY Exercise of conversion of derivative security	$13,390 $1.03 p/Share	13,000 Added 8.65%	137,228 Common Stock
Dec 14 2023	SELL Open market or private sale	$28,559 $12.02 p/Share	2,376 Reduced 1.88%	124,228 Common Stock
Dec 11 2023	SELL Open market or private sale	$14,793 $10.72 p/Share	1,380 Reduced 1.08%	126,604 Common Stock
Dec 06 2023	SELL Open market or private sale	$22,482 $12.01 p/Share	1,872 Reduced 1.44%	127,984 Common Stock
Dec 04 2023	SELL Open market or private sale	$8,178 $12.01 p/Share	681 Reduced 0.52%	129,856 Common Stock
Nov 15 2023	BUY Grant, award, or other acquisition	-	89,742 Added 40.74%	130,537 Common Stock
Sep 18 2023	SELL Open market or private sale	$12,138 $9.41 p/Share	1,290 Reduced 3.07%	40,795 Common Stock
Sep 12 2023	SELL Open market or private sale	$14,542 $10.41 p/Share	1,397 Reduced 3.21%	42,085 Common Stock
Jun 15 2023	SELL Open market or private sale	$120,300 $12.03 p/Share	10,000 Reduced 18.7%	43,482 Common Stock
Jun 13 2023	SELL Open market or private sale	$523,997 $12.66 p/Share	41,390 Reduced 43.63%	53,482 Common Stock
Jun 13 2023	BUY Exercise of conversion of derivative security	$41,200 $1.03 p/Share	40,000 Added 29.97%	93,482 Common Stock
Mar 14 2023	SELL Open market or private sale	$17,475 $13.33 p/Share	1,311 Reduced 2.33%	54,872 Common Stock
Dec 12 2022	SELL Open market or private sale	$3,391 $10.87 p/Share	312 Reduced 0.55%	56,183 Common Stock
Dec 09 2022	BUY Grant, award, or other acquisition	-	31,000 Added 35.43%	56,495 Common Stock
Sep 20 2022	SELL Sale (or disposition) back to the issuer	$11,508 $13.7 p/Share	840 Reduced 3.19%	25,495 Common Stock
Sep 15 2022	SELL Sale (or disposition) back to the issuer	$4,580 $14.05 p/Share	326 Reduced 1.22%	26,335 Common Stock
Jun 14 2022	SELL Sale (or disposition) back to the issuer	$1,648 $4.95 p/Share	333 Reduced 1.23%	26,661 Common Stock
Mar 11 2022	SELL Open market or private sale	$2,689 $8.73 p/Share	308 Reduced 1.13%	26,994 Common Stock
Dec 10 2021	BUY Grant, award, or other acquisition	-	16,696 Added 37.95%	27,302 Common Stock
Sep 21 2021	SELL Open market or private sale	$7,926 $16.11 p/Share	492 Reduced 4.43%	10,606 Common Stock
Sep 20 2021	SELL Open market or private sale	$5,729 $15.61 p/Share	367 Reduced 3.2%	11,098 Common Stock

RWS

Richard William Scalzo

SVP, Head of Finance & Admin.

Waltham, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DYN shares.

Notify only if

Value

Insider Trading

Get notified when an Dyne Therapeutics, Inc. insider buys or sells DYN shares.

Notify only if

Operation

Value

Type

News

Receive news related to Dyne Therapeutics, Inc.

Track Activities on DYN

Account